Emerging Risk Factors for Coronary Heart Disease: A Summary of Systematic Reviews Conducted for the U.S. Preventive Services Task Force

University of Utah, Salt Lake City, Utah, United States
Annals of internal medicine (Impact Factor: 17.81). 10/2009; 151(7):496-507. DOI: 10.7326/0003-4819-151-7-200910060-00010
Source: PubMed


Traditional risk factors do not explain all of the risk for incident coronary heart disease (CHD) events. Various new or emerging risk factors have the potential to improve global risk assessment for CHD.
To summarize the results of 9 systematic reviews of novel risk factors to help the U.S. Preventive Services Task Force (USPSTF) evaluate the factors' clinical usefulness.
Results from a MEDLINE search for English-language articles published from 1966 to September 2008, using the Medical Subject Heading terms cohort studies and cardiovascular diseases in combination with terms for each risk factor.
Studies were included if the participants had no baseline cardiovascular disease and the investigators adjusted for at least 6 Framingham risk factors.
Study quality was evaluated by using USPSTF criteria and overall quality of evidence for each risk factor by using a modified version of the Grading of Recommendations, Assessment, Development, and Evaluation framework. Each factor's potential clinical value was evaluated by using a set of criteria that emphasized the importance of the effect of that factor on the reclassification of intermediate-risk persons.
9 systematic reviews were conducted. C-reactive protein (CRP) was the best candidate for use in screening and the most rigorously studied, but evidence that changes in CRP level lead to primary prevention of CHD events is inconclusive. The other evaluated risk factors were coronary artery calcium score as measured by electron-beam computed tomography, lipoprotein(a) level, homocysteine level, leukocyte count, fasting blood glucose, periodontal disease, ankle-brachial index, and carotid intima-media thickness. The availability and validity of the evidence varied considerably across the risk factors in terms of aggregate quality, consistency of findings, and applicability to intermediate-risk persons in the general population. For most risk factors, no studies assessed their usefulness for reclassifying intermediate-risk persons.
Because of lack of access to original data, no firm conclusions could be drawn about differences in risk prediction among racial and ethnic groups. The review did not emphasize within-cohort comparisons of multiple risk factors.
The current evidence does not support the routine use of any of the 9 risk factors for further risk stratification of intermediate-risk persons.

Download full-text


Available from: Mark Helfand
  • Source
    • "Although some of these variables increase with age, the predictive accuracy of traditional risk estimates that include the aforementioned variables, such as Framingham risk scores (FRS), the Prospective Cardiovascular Mὒnster (PROCAM) score and the European Society of Cardiology Systematic Coronary Risk Evaluation (SCORE) either over-or underestimates actual risk in a large number of individuals (Vasan 2006; Koenig 2007; Cohn 2013). Therefore, other measures, such as genetic, inflammatory and coagulation markers, and various tests for subclinical disease have been sought (Helfand et al. 2009; Wang 2011; Ge & Wang 2012). The quantification of vascular and endothelial dysfunction (Deanfield et al. 2007) is a recently emerging early marker for CVD and is usually achieved by employing techniques such as ultrasound flow-mediated dilation (FMD), pulse wave analysis (PWA), plethysmography and iontophoresis (Ray et al. 2014). "
    [Show abstract] [Hide abstract]
    ABSTRACT: To compare flicker-induced retinal vessel diameter changes in varying age groups with low cardiovascular risk. Retinal vascular reactivity to flicker light was assessed by means of dynamic retinal vessel analysis in 57 participants aged 19-30 years, 75 participants aged 31-50 years and 62 participants aged 51-70 years participants. Other assessments included carotid intima-media thickness (c-IMT), augmentation index (AIx), blood pressure profiles, blood lipid metabolism markers and Framingham risk scores (FRS). Retinal arterial dilation amplitude (DA) and postflicker percentage constriction (MC%) were significantly decreased in the oldest group compared to the middle-aged (p = 0.028; p = 0.021) and youngest group (p = 0.003; p = 0.026). The arterial constriction slope (SlopeAC ) was also decreased in the oldest group compared to the youngest group (p = 0.027). On the venous side, MC% was decreased in the middle-aged and oldest groups in comparison with the youngest group (p = 0.015; p = 0.010, respectively). Additionally, men exhibited increased arterial DA (p = 0.007), and percentage dilation (MD%, p < 0.001) in comparison with women, but only in the youngest age group. Both AIx and c-IMT scores increased with age (both p < 0.001); however, no correlations were found between the observed differences in the measured retinal vascular function and systemic parameters. In individuals with low cardiovascular risk, there are age-related differences in flicker-induced retinal vessel diameter changes throughout the entire functional response curve for arteries and veins. Gender differences mainly affect the arterial dilatory phase and are only present in young individuals. © 2015 Acta Ophthalmologica Scandinavica Foundation. Published by John Wiley & Sons Ltd.
    Full-text · Article · Jul 2015 · Acta ophthalmologica
  • Source
    • "PWV, IMT) remains limited, as they demonstrate a fair or poor overall strength of evidence and lack applicability. [3], [60], [61] However, in recent studies, compelling evidence showed that LOKI constitutes a solid candidate to become a valuable image-based biomarker for cardiovascular disease, as it is associated with the presence of cardiovascular risk factors [7], [8], [9], [10] and with the occurrence of clinical events. [11] Moreover, LOKI-induced forces are likely to be associated with wall shear strain, which is a key factor in the development of atherosclerosis and plays a crucial role in vasa vasorum circulation as well as endothelial function. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Purpose: Tracking the motion of biological tissues represents an important issue in the field of medical ultrasound imaging. However, the longitudinal component of the motion (i.e. perpendicular to the beam axis) remains more challenging to extract due to the rather coarse resolution cell of ultrasound scanners along this direction. The aim of this study is to introduce a real-time beamforming strategy dedicated to acquire tagged images featuring a distinct pattern in the objective to ease the tracking. Methods: Under the conditions of the Fraunhofer approximation, a specific apodization function was applied to the received raw channel data, in real-time during image acquisition, in order to introduce a periodic oscillations pattern along the longitudinal direction of the radio frequency signal. Analytic signals were then extracted from the tagged images, and sub-pixel motion tracking of the intima-media complex was subsequently performed offline, by means of a previously introduced bi-dimensional analytic phase-based estimator. Results: Our framework was applied in vivo on the common carotid artery from 20 young healthy volunteers and 6 elderly patients with high atherosclerosis risk. Cine-loops of tagged images were acquired during three cardiac cycles. Evaluated against reference trajectories manually generated by three experienced analysts, the mean absolute tracking error was 98±84 μm and 55±44 μm in the longitudinal and axial directions, respectively. These errors corresponded to 28±23 % and 13±9 % of the longitudinal and axial amplitude of the assessed motion, respectively. Conclusion: The proposed framework enables tagged ultrasound images of in vivo tissues to be acquired in real-time. Such unconventional beamforming strategy contributes to improve tracking accuracy and could potentially benefit to the interpretation and diagnosis of bio-medical images.
    Full-text · Article · Dec 2014 · Medical Physics
    • "The results presented in this article are drawn from six CPG— two RA-specific [36] [37], and four reports on CVR management in the general population [38] [39] [40] [41]—nine SR and MA [42] [43] [44] [45] [46] [47] [48] [49] [50], and four SR without MA [51] [52] [53] [54]. Of those SR performed specifically for this analysis, we included seven original articles [55] [56] [57] [58] [59] [60] [61] from 438 studies compiled (not counting duplicates). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Objectives Last recommendations regarding cardiovascular risk (CVR) in Rheumatoid Arthritis (RA) patients were developed by the EULAR group in 2010. The aim is to update evidence based recommendations about this worrying health problem. Methods We assembled a multidisciplinary workgroup (rheumatologists, endocrinologist, cardiologist, and epidemiologist) and a panel of 28 expert rheumatologists. The study was carried out in two big phases: identifying key areas in the prevention and management of CVR; and developing a set of recommendations based on a review of the available scientific evidence and use of the Delphi consensus technique. All this has been developed according to an updating process of evidence-based recommendations. Results Twenty-five recommendations were made addressing three complementary areas: CVR assessment tools, patient eligibility for assessment, and treatment strategies for control of CVR. The grade of the recommendations was not substantially modified compared to the original EULAR recommendations, except in two of them which were upgraded from C to B. These two recommendations are the ones related to the use of corticosteroids and smoking cessation. The new developed recommendations address these two areas: CVR assessment and treatment strategies for control of CVR. Conclusions There are substantial gaps in the current knowledge that do not allow classifying properly RA patients based on their actual CVR and to accurately identify those patients who would benefit from CVR assessment. Consequently, studies designed to determine the causal effects of RA disease characteristics on cardiovascular morbidity/mortality and to identify patients at high risk of cardiovascular disease are still needed.
    No preview · Article · Aug 2014 · Seminars in arthritis and rheumatism
Show more